Europe • Euronext Paris • EPA:AKE • FR0010313833
Taking everything into account, AKE scores 4 out of 10 in our fundamental rating. AKE was compared to 68 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE is cheap, but on the other hand it scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.89% | ||
| ROE | 1.76% | ||
| ROIC | 2.77% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.4% | ||
| PM (TTM) | 1.38% | ||
| GM | 18.68% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 17.51 | ||
| Altman-Z | 1.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.26 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.87 | ||
| Fwd PE | 10.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.92 | ||
| EV/EBITDA | 6.09 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7% |
ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.
ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.
The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 214.17%.